| 1 bis 50 von 124 | Qualität fynup-Ratio | Kosten Lfd. Kosten | Ethik Nachhaltigkeit | |
|---|---|---|---|---|
|
B
|
Polar Capital Fd.BiotechnologyFd.S USD
|
74
|
0,86%
|
75
|
|
B
|
Franklin Biotechnology Disc.F.I USD
|
75
|
0,97%
|
75
|
|
B
|
Pictet-Biotech I
|
75
|
1,1%
|
74
|
|
B
|
Pictet-Biotech I
|
74
|
1,1%
|
74
|
|
B
|
Polar Capital Fd.BiotechnologyFd.I GBP
|
74
|
1,11%
|
75
|
|
B
|
Polar Capital Fd.BiotechnologyFd.I USD
|
74
|
1,11%
|
75
|
|
B
|
Polar Capital Fd.BiotechnologyFd.I EUR
|
74
|
1,11%
|
75
|
|
B
|
Candriam Equities L Biotech.C USD Dis
|
83
|
1,91%
|
77
|
|
B
|
Pictet-Biotech Z
|
59
|
0,1%
|
74
|
|
B
|
Bellevue Biotech DT CHF
|
73
|
1,21%
|
76
|
|
B
|
Polar Capital Fd.Biotechnology R EUR
|
78
|
1,61%
|
75
|
|
B
|
Candriam Equities L Biotech.V USD Acc
|
64
|
0,65%
|
77
|
|
B
|
Pictet-Biotech I dy
|
71
|
1,1%
|
73
|
|
B
|
Candriam Equities L Biotech.C USD Acc
|
78
|
1,88%
|
77
|
|
B
|
Bellevue F. (L) -B.Biotech I CHF
|
73
|
1,5%
|
76
|
|
B
|
Bellevue F. (L) -B.Biotech I EUR
|
73
|
1,5%
|
76
|
|
B
|
JPM-Thematics-Gen.Therap.C2 (acc) CHF H
|
60
|
0,49%
|
76
|
|
B
|
JPM-Thematics-Gen.Therap.C2 (dist) CHF H
|
60
|
0,49%
|
76
|
|
B
|
Bellevue F. (L) -B.Biotech I USD
|
73
|
1,5%
|
75
|
|
B
|
JPM-Thematics-Gen.Therap.C2 (acc) USD
|
60
|
0,49%
|
76
|
|
B
|
JPM-Thematics-Gen.Therap.C2 (dist) USD
|
60
|
0,49%
|
76
|
|
B
|
Candriam Equities L Biotech.R USD Acc
|
67
|
1,1%
|
77
|
|
B
|
DekaLux-BioTech CF
|
73
|
1,52%
|
74
|
|
B
|
JPM-Thematics-Gen.Therap.C2 (acc) EUR H
|
58
|
0,49%
|
76
|
|
B
|
JPM-Thematics-Gen.Therap.C2 (dist) EUR H
|
58
|
0,49%
|
76
|
|
B
|
DWS Biotech LC
|
72
|
1,5%
|
74
|
|
B
|
Pictet-Biotech HI
|
68
|
1,15%
|
74
|
|
B
|
Polar Capital Fd.BiotechnologyFd. R GBP
|
73
|
1,61%
|
75
|
|
B
|
Polar Capital Fd.BiotechnologyFd. R USD
|
73
|
1,61%
|
75
|
|
B
|
Pictet-Biotech P
|
78
|
2%
|
74
|
|
B
|
UBS (Lux) E.F.-Biotech (USD) P a.USD
|
78
|
2,1%
|
74
|
|
B
|
Allianz Biotechnologie A
|
76
|
2,04%
|
76
|
|
B
|
DWS Biotech FC
|
59
|
0,75%
|
74
|
|
B
|
Allianz Biotechnologie R
|
64
|
1,16%
|
76
|
|
B
|
SEB Concept Biotechnology D
|
69
|
1,56%
|
74
|
|
B
|
Candriam Equities L Biotech.I EUR Acc H
|
58
|
0,8%
|
77
|
|
B
|
ERSTE Stock Biotec R01 VTIA
|
75
|
2,07%
|
76
|
|
B
|
Bellevue Biotech AA CHF
|
72
|
1,81%
|
76
|
|
B
|
JPM-Thematics-Gen.Therap.C (acc) USD
|
55
|
0,56%
|
76
|
|
B
|
Pictet-Biotech P dy
|
75
|
2%
|
74
|
|
B
|
Franklin Biotechnology Disc. F.A SGD
|
72
|
1,82%
|
75
|
|
B
|
JPM-Thematics-Gen.Therap.A (acc) USD
|
59
|
0,93%
|
76
|
|
B
|
DWS Biotech TFC
|
59
|
0,9%
|
74
|
|
B
|
UBS (Lux) E.F.-Biotech (USD) Q a.USD
|
62
|
1,08%
|
74
|
|
B
|
JPM-Thematics-Gen.Therap.C (acc) CHF H
|
54
|
0,56%
|
76
|
|
B
|
JPM-Thematics-Gen.Therap.A (acc) CHF H
|
59
|
1,02%
|
76
|
|
B
|
JPM-Thematics-Gen.Therap.A (dist) CHF H
|
59
|
1,02%
|
76
|
|
B
|
JPM-Thematics-Gen.Therap.A (dist) USD
|
59
|
1,02%
|
76
|
|
B
|
JPM-Thematics-Gen.Therap.A (acc) EUR H
|
58
|
0,93%
|
76
|
|
B
|
Franklin Biotechnology Disc. F.A USD
|
70
|
1,82%
|
75
|
6 Schritte
zur finanziellen Gelassenheit
Jetzt zum Newsletter anmelden und kostenloses eBook mit wertvollen Tipps sichern.